Application of decellularized scaffold combined with loaded nanoparticles for heart valve tissue engineering in vitro

Abstract

The purpose of this study was to fabricate decelluarized valve scaffold modified with polyethylene glycol nanoparticles loaded with transforming growth factor-β1 (TGF-β1), by which to improve the extracellular matrix microenvironment for heart valve tissue engineering in vitro. Polyethylene glycol nanoparticles were obtained by an emulsion-crosslinking method, and their morphology was observed under a scanning electron microscope. Decelluarized valve scaffolds, prepared by using trypsinase and TritonX-100, were modified with nanoparticles by carbodiimide, and then TGF-β1 was loaded into them by adsorption. The TGF-β1 delivery of the fabricated scaffold was measured by asing enzyme-linked immunosorbent assay. Whether unseeded or reseeded with myofibroblast from rats, the morphologic, biochemical and biomechanical characteristics of hybrid scaffolds were tested and compared with decelluarized scaffolds under the same conditions. The enzyme-linked immunosorbent assay revealed a typical delivery of nanoparticles. The morphologic observations and biological data analysis indicated that fabricated scaffolds possessed advantageous biocompatibility and biomechanical property beyond decelluarized scaffolds. Altogether this study proved that it was feasible to fabricate the hybrid scaffold and effective to improve extracellular matrix microenvironment, which is beneficial for an application in heart valve tissue engineering.

Keywords

heart valve tissue engineering / polyethylene glycol nanoparticle / transforming growth factor-β1 / decellularized scaffold

References

[1] NeuenschwanderS., HoerstrupS.P.. Heart valve tissue engineering. Transpl Immunol, 2004, 12(3–4): 359-365

[2] FlanaganT.C., PanditA.. Living artificial heart valve alternatives: a review. Eur Cell Mater, 2003, 20(6): 28-45

[3] ShinokaT., BreuerC.K., TanelR.E., et al.. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg, 1995, 60(6Suppl): S513-S516

[4] TeradaS., SatoM., SevyA., et al.. Tissue engineering in the twenty-first century. Yonsei Med J, 2000, 41(6): 685-691

[5] SchoenF.J.. New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, February 12, 2006. Cardiovasc Pathol, 2006, 15(5): 271-279

[6] OttH.C., MatthiesenT.S., GohS.K., et al.. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med, 2008, 14(2): 213-221

[7] RiederE., KasimirM.T., SilberhumerG., et al.. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg, 2004, 127(2): 399-405

[8] DongN.G., YeX.F., ShiJ.W., et al.. Comparison on decellularizing approaches of biological scaffold with porcine aortic valve for tissue engineering heart valve. Chin J Exp Surg (Chinese), 2005, 22(3): 377

[9] ChouY.M., DongN.G., YeX.F., et al.. Effects of transforming growth factor-β1 on constructing tissue engineering heart valves in vitro. Chin J Exp Surg (Chinese), 2006, 23(10): 1275

[10] XuX.D., WangB., WangZ.C., et al.. Fabrication of fast responsive, thermosensitive poly(N-isopropylacrylamide) hydrogels by using diethyl ether as precipitation agent. J Biomed Mater Res A, 2008, 86(4): 1023-1032

[11] XuX.D., WeiH., ZhangX.Z., et al.. Fabrication and characterization of a novel composite PNIPAAm hydrogel for controlled drug release. J Biomed Mater Res A, 2007, 81(2): 418-426

[12] DavisM.E., HsiehP.C., GrodzinskyA.J., et al.. Custom design of the cardiac microenvironment with biomaterials. Circ Res, 2005, 97(1): 8-15

[13] LutolfM.P., HubbellJ.A.. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol, 2005, 23(1): 47-55

[14] QuanC.Y., ChangC., WeiH., et al.. Dual targeting of a thermosensitive nanogel conjugated with transferrin and RGD-containing peptide for effective cell uptake and drug release. Nanotechnology, 2009, 20(33): 335 101

[15] DreherM.R., ChilkotiA.. Toward a systems engineering approach to cancer drug delivery. J Natl Cancer Inst, 2007, 99(13): 983-985

[16] ZeugolisD.I., PaulR.G., AttenburrowG.. Extruded collagen-polyethylene glycol fibers for tissue engineering applications. J Biomed Mater Res B Appl Biomater, 2008, 85(2): 343-352

[17] HalstenbergS., PanitchA., RizziS., et al.. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules, 2002, 3(4): 710-723

[18] HiemstraC., AaL.J., ZhongZ., et al.. Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules, 2007, 8(5): 1548-1556

[19] QuanC.Y., WeiH., SunY.X., et al.. Polyethyleneimine modified biocompatible poly(N-isopropylacrylamide)-based nanogels for drug delivery. J Nanosci Nanotechnol, 2008, 8(5): 2377-2384

[20] HongH., DongG.N., ShiW.J., et al.. Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro. ASAIO J, 2008, 54(6): 627-632

[21] ShiJ., DongN., SunZ.. Immobilization of decellularized valve scaffolds with Arg-Gly-Asp-containing peptide to promote myofibroblast adhesion. J Huazhong Univ Sci Technol [Med Sci], 2009, 29(4): 503-507

[22] Schenke-LaylandK., OpitzF., GrossM., et al.. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals—an in vitro study. Cardiovasc Res, 2003, 60(3): 497-509

[23] HerselU., DahmenC., KesslerH.. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, 2003, 24(24): 4385-4415

[24] BoontheekulT., MooneyD.J.. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol, 2003, 14(5): 559-665

[25] HamidiM., AzadiA., RafieiP.. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev, 2008, 60(15): 1638-1649

[26] HongH., DongN., ShiJ., et al.. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study. Artif Organs, 2009, 33(7): 554-558

[27] SoppimathK.S., AminabhaviT.M., KulkarniA.R., et al.. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001, 70(1–2): 1-20

[28] PanyamJ., LabhasetwarV.. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 2003, 55(3): 329-347

[29] HongH., DongN.G., ShiJ.W.. Regulatory mechanism of transforming growth factor-beta 1 on mechanical properties of tissue engineering heart valve. Acad J Second Military Med Univ (Chinese), 2009, 30(2): 124-127